Zai Lab Statistics
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
23.94-1.38 (-5.43%)
Market open · Delayed 15 min · as of Oct 8, 12:29 PM ET
Zai Lab by the numbers
Zai Lab has a market capitalization of $2.69 billion based on 112.27M shares outstanding. With trailing EPS of $-1.70, Zai Lab is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.7% below its 50-day average and 16.6% above its 200-day average.
Average daily trading volume is 944.83K shares, or about $22.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ZLAB valuation vs. peer median
| Metric | ZLAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.69B | $2.78B | -3% |
| Avg. volume | 944.83K | 2.31M | -59% |
Peer median across 8 companies: ELVN, RCUS, DYN, ARQT, PGEN, MRVI, LQDA, NAMS.
Valuation
- Market cap
- $2.69B
- Price / sales (latest FY)
- 5.84
- EPS (TTM)
- $-1.70
- Shares outstanding
- 112.27M
Price and trading
- Previous close
- 25.31
- Open
- 24.33
- Day range
- 23.76 – 24.53
- 52-week range
- 15.96 – 33.65
- 52-week change
- -23.05%
- Beta
- —
- Volume
- 339.40K
- Average volume
- 944.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.69B
- Forward Pe
- -11.34
- Eps
- -1.70
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 33.65
- Week52 Low
- 15.96
- Avg Volume
- 944.83K
- Shares Outstanding
- 112.27M
- Ma50
- 24.61
- Ma200
- 20.52
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -28.87%
- Pct From52w Low
- 49.97%